SaraEmilyBachertMD

PubMed

• Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC.
  Nishino, M., Zhang, T., LoPiccolo, J., Paweletz, C., Gokhale, P., Ivanova, E., Saldanha, A., Lockwood, W., Somwar, R., Jänne, P., Odintsov, I., Makarem, M., Bachert, S...> ;Journal of Thoracic Oncology. 2023 Dec 26
• 1 citations
  Case report: A unique presentation of a high-grade neuroepithelial tumor with EWSR1::PATZ1 fusion with diagnostic, molecular, and therapeutic insights.
  Andre Ene, Jing Di, Janna H Neltner, Susanne M Arnold, Jill M Kolesar, John L Villano, Sara E Bachert, Derek B Allison, Pittman, T.> ;Frontiers in Oncology. 2023 Jan 1
• 1 citations
  Malignant phyllodes tumor metastatic to pancreas.
  Sara Emily Bachert, Rachel L. Stewart, Luis Samayoa, Suleiman Massarweh> ;The Breast Journal. 2020 Jul 27
• 4 citations
  Alternatives to Transfusion.
  Sara Emily Bachert, Prerna Dogra, Leonard I. Boral> ;American Journal of Clinical Pathology. 2019 Nov 2
• Metachronous cellular angiolipomas of the breast.
  Sara Emily Bachert, Richard A. Gibbs, Paula S. Ginter, Rachel L. Stewart> ;The Breast Journal. 2019 Jul 12
• Join now to see all